Sun Pharma issues recall of gout drug due to contamination
11 Mar 2024 //
FIERCE PHARMA
Enforcement Report - Week of February 14, 2024
14 Feb 2024 //
FDA
Torrent Pharma`s Generic Febuxostat Receives Approval in the U.S.
19 Dec 2023 //
FDA
Krka`s febuxostat Receives Approval in Europe
15 Dec 2023 //
EMA
We are extremely happy to share the successful filling of Febuxostat USDMF with the USFDA
18 Feb 2023 //
PRESS RELEASE
Zydus gets US FDA final nod for Febuxostat tablets for treating high uric acid
15 Jan 2023 //
ECONOMIC TIMES
Zydus` Generic Febuxostat Receives Approval in the U.S.
09 Jan 2023 //
FDA
Identrix`s Generic Timolol Maleate Receives Approval in the U.S.
13 Dec 2021 //
FDA
Alkem Lab`s Generic Febuxostat Receives Approval in the U.S.
06 Dec 2021 //
FDA
Sunshine Lake Generic Febuxostat Receives Approval in US
09 Jun 2020 //
FDA
MSN Labs subsidiary, Novadoz Pharma gets US FDA approval for generic Uloric
01 Jan 2020 //
PHARMABIZ
Indoco Remedies Generic Febuxostat Receives Approval in US
31 Dec 2019 //
FDA
MSN`s Generic Febuxostat Receives Approval in US
31 Dec 2019 //
FDA
Indoco Remedies gets US FDA approval for febuxostat tablets
31 Dec 2019 //
PHARMABIZ
Novadoz Pharmaceuticals/MSN Labs granted FDA Approval of generic Febuxostat
31 Dec 2019 //
PR NEWSWIRE
Health Canada Issues Recall of Teijin Limited ULORIC ® (febuxostat)
05 Nov 2019 //
HEALTH CANADA
West-Ward Pharms Int`s Generic Febuxostat Receives Approval in US
17 Oct 2019 //
FDA
Sun Pharm`s generic FEBUXOSTAT Receives Approval in US
01 Jul 2019 //
FDA
ALEMBIC PHARMS` generic FEBUXOSTAT Receives Approval in US
01 Jul 2019 //
FDA
MYLAN PHARMS` generic FEBUXOSTAT Receives Approval in US
01 Jul 2019 //
FDA
Takeda sets December deadline for U.S. employees` Boston move
27 Jun 2019 //
FIERCE PHARMA
MSN Laboratories` Generic Febuxostat Receives Tentative Approval In US
26 Jun 2019 //
USA
FDA restricts Takeda`s gout drug Uloric on death-risk data
23 Feb 2019 //
FIERCE PHARMA
FDA Adds Boxed Warning To Gout Drug Uloric
21 Feb 2019 //
RTTNEWS
Torrent Pharms` Generic Febuxostat Receives Tentative Approval in US
05 Feb 2019 //
FDA
EMA’s CHMP Recommends 6 New Meds, Releases Outcome of Sartan Investigation
01 Feb 2019 //
RAPS
Zydus Pharms` Generic Febuxostat Receives Tentative Approval in US
21 Dec 2018 //
FDA
Uloric® (Febuxostat): Teijin Limited et al v. MSN Laboratories Private
14 Jun 2018 //
PATENT LITIGATION
Newer gout drug poses risk to heart patients
12 Mar 2018 //
REUTERS
Mylan`s Febuxostat Receives Approval In Europe
20 Oct 2017 //
EMA
Macleods Pharm’s Generic Febuxostat Receives Approval In US
31 Jul 2017 //
FDA
Design of experiment approach in development of febuxostat nanocrystal
13 Sep 2016 //
PHARMA-EXCIPIENTS
Alembic Pharma gets tentative nod from USFDA for Febuxostat
05 Jul 2016 //
ECONOMIC TIMES
Japan`s MHLW slated to review Nippon Boehringer high blood pressure combo
13 Apr 2016 //
FIERCE PHARMA ASIA
TWi Biotechnology Inc. Reports Positive Interim Results from AC-201 CR
24 Dec 2015 //
PR NEWS WIRE
New Indication for Teijin Pharma`s Febuxostat in Europe
02 Jul 2015 //
PHARMA ASIA
AZ`s phase III gout data frustrates firm
16 Jun 2015 //
PM LIVE
Higher dose of AZ` gout drug hits PhIII goals
15 Jun 2015 //
PHARMA TIMES
CymaBay Drug Not Better Than Current Care In Reducing Uric Acid
25 Feb 2015 //
REUTERS
Astrazeneca`s $1.3B Gout Drug Comes Under EU Scrutiny
24 Jan 2015 //
FIERCE BIOTECH